Logo.jpg
Blue Biofuels Receives Canadian Patent on CTS Process
May 21, 2024 17:37 ET | Blue Biofuels, Inc.
PALM BEACH GARDENS, FL, May 21, 2024 (GLOBE NEWSWIRE) -- Blue Biofuels, Inc. (OTCQB: BIOF). Blue Biofuels, Inc., (“the Company”) is pleased to announce that it has received a Notice of Allowance in...
Logo.png
GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators
March 14, 2024 08:45 ET | GRI Bio, Inc.
Company advancing an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases Ongoing efforts to build a robust global patent estate for a...
SeaStar_SM_LogoCard.png
SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology
February 01, 2024 08:30 ET | SeaStar Medical Holding Corporation
DENVER, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
60Degrees_logo_RGB_Logo.jpg
60 Degrees Pharmaceuticals Awarded Canadian Patent Covering Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects
July 31, 2023 07:59 ET | Sixty Degrees Pharmaceuticals
Patent provides exclusive use of tafenoquine for prevention of malaria in malaria-naive individuals in Canada until late 2035.Tafenoquine is the active molecule in 60 Degrees Pharmaceuticals’...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 31, 2017 07:30 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 31, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today the issuance of European Patent No. 1615623 titled...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation
December 16, 2014 08:38 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the continued expansion of Elite's intellectual property...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally
March 10, 2014 07:46 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 10, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the expansion of intellectual property protection surrounding...
P2D Bioscience Announces Enhanced Patent Position for Lead ADHD Drug
April 26, 2011 10:15 ET | P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 26, 2011) - www.p2dinc.com ...